Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
Diabetes Care|September 28, 2002
Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetesEeva S Leinonen, Jukka T Salonen, Riitta M Salonen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 28, 2007
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery diseaseMarit Granér, Juhani Kahri, Marjut Varpula, et al.
European Journal of Human Genetics : EJHG|November 29, 2020
High-resolution population-specific recombination rates and their effect on phasing and genotype imputationShabbeer Hassan, Ida Surakka, Marja-Riitta Taskinen, et al.
Journal of Internal Medicine|November 24, 2021
Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuriaFanny Jansson Sigfrids, Lars Stechemesser, Emma H Dahlström, et al.
Annals of Medicine|May 9, 2013
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest painMarit Granér, Emmi Tikkanen, Olga Rimpilä, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrateMarja-Riitta Taskinen, David R Sullivan, Christian Ehnholm, et al.
Plos One|March 16, 2007
Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortalityJenny Fredriksson, Dragi Anevski, Peter Almgren, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemiasJussi Naukkarinen, Emma Nilsson, Heikki A Koistinen, et al.
Bioinformatics (Oxford, England)|July 25, 2007
Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profilesMarko Sysi-Aho, Aki Vehtari, Vidya R Velagapudi, et al.
Journal of Lipid Research|October 19, 2004
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractionsMartin Adiels, Chris Packard, Muriel J Caslake, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
Diabetes Care|September 28, 2002
Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetesEeva S Leinonen, Jukka T Salonen, Riitta M Salonen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 28, 2007
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery diseaseMarit Granér, Juhani Kahri, Marjut Varpula, et al.
European Journal of Human Genetics : EJHG|November 29, 2020
High-resolution population-specific recombination rates and their effect on phasing and genotype imputationShabbeer Hassan, Ida Surakka, Marja-Riitta Taskinen, et al.
Journal of Internal Medicine|November 24, 2021
Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuriaFanny Jansson Sigfrids, Lars Stechemesser, Emma H Dahlström, et al.
Annals of Medicine|May 9, 2013
Diagnostic efficacy of myeloperoxidase to identify acute coronary syndrome in subjects with chest painMarit Granér, Emmi Tikkanen, Olga Rimpilä, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2009
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrateMarja-Riitta Taskinen, David R Sullivan, Christian Ehnholm, et al.
Plos One|March 16, 2007
Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortalityJenny Fredriksson, Dragi Anevski, Peter Almgren, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemiasJussi Naukkarinen, Emma Nilsson, Heikki A Koistinen, et al.
Bioinformatics (Oxford, England)|July 25, 2007
Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profilesMarko Sysi-Aho, Aki Vehtari, Vidya R Velagapudi, et al.
Journal of Lipid Research|October 19, 2004
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractionsMartin Adiels, Chris Packard, Muriel J Caslake, et al.
Pageof 23